DRUG-INDUCED VASCULITES

[1]  D A Bloch,et al.  The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis. , 2010, Arthritis and rheumatism.

[2]  W. Schaffner,et al.  The risk of vaccination--the importance of "negative" studies. , 2001, The New England journal of medicine.

[3]  S Suissa,et al.  Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group. , 2001, The New England journal of medicine.

[4]  A M Walker,et al.  Hepatitis B vaccination and the risk of multiple sclerosis. , 2001, The New England journal of medicine.

[5]  S. D. House,et al.  Chronic cocaine alters hemodynamics and leukocyte-endothelial interactions in rat mesenteric venules. , 2000, Life sciences.

[6]  P. Merkel,et al.  Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. , 2000, Arthritis and rheumatism.

[7]  R. Pauwels,et al.  Leukotriene Modifiers and Churg-Strauss Syndrome , 1999, Drug safety.

[8]  Smith,et al.  Dermatological adverse effects with the antimalarial drug mefloquine: a review of 74 published case reports , 1999, Clinical and experimental dermatology.

[9]  D. L. Le Couteur,et al.  Focal necrotising vasculitis with secondary myositis following fluoxetine administration. , 1999, Australian and New Zealand journal of medicine.

[10]  T. Rikimaru,et al.  Churg-Strauss syndrome after corticosteroid withdrawal in an asthmatic patient treated with pranlukast. , 1999, The Journal of allergy and clinical immunology.

[11]  G. Woodrow,et al.  Ecstasy-induced renal vasculitis. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  R. L. Green,et al.  Churg-Strauss syndrome after zafirlukast in two patients not receiving systemic steroid treatment , 1999, The Lancet.

[13]  P. Merkel,et al.  Alternating antineutrophil cytoplasmic antibody specificity: drug-induced vasculitis in a patient with Wegener's granulomatosis. , 1999, Arthritis and rheumatism.

[14]  M. Pillinger,et al.  Wegener's granulomatosis in a patient receivingpropylthiouracil for Graves' disease , 1998 .

[15]  P. Anthony,et al.  Necrotizing renal vasculopathy resulting in chronic renal failure after ingestion of methamphetamine and 3,4-methylenedioxymethamphetamine ('ecstasy') , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[16]  D. Knoell,et al.  Churg-Strauss syndrome associated with zafirlukast. , 1998, Chest.

[17]  A. Churg,et al.  Zafirlukast and Churg-Strauss syndrome. , 1998, JAMA.

[18]  R. Katz,et al.  Zafirlukast and Churg-Strauss syndrome. , 1998, JAMA.

[19]  H. Rommes,et al.  Quality of care for elderly patients with pneumonia. , 1998, JAMA.

[20]  T. Craig,et al.  Churg-Strauss syndrome associated with zafirlukast. , 1998, The Journal of the American Osteopathic Association.

[21]  G. Pizzolato,et al.  Cerebral vasculitis during FK 506 treatment in a liver transplant patient , 1998, Neurology.

[22]  I. Ahmed,et al.  Cytosine arabinoside-induced vasculitis. , 1998, Mayo Clinic proceedings.

[23]  J. Drazen,et al.  Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast. , 1998, JAMA.

[24]  D. Grant,et al.  Arteritis and increased intracellular calcium as a possible mechanism for tacrolimus-related cardiac toxicity in a pediatric transplant recipient. , 1997, Transplantation.

[25]  D. Josefson.  Asthma drug linked with Churg-Strauss syndrome , 1997, BMJ.

[26]  V. Tron,et al.  Microscopic polyangiitis after influenza vaccination. , 1997, The Journal of rheumatology.

[27]  P. Merkel,et al.  Prevalence of Antineutrophil Cytoplasmic Antibodies in a Large Inception Cohort of Patients with Connective Tissue Disease , 1997, Annals of Internal Medicine.

[28]  K. Hiromura,et al.  Case of propylthiouracil-induced vasculitis associated with anti-neutrophil cytoplasmic antibody (ANCA); review of literature. , 1997, Clinical nephrology.

[29]  R. Falk,et al.  ANCA small-vessel vasculitis. , 1997, Journal of the American Society of Nephrology : JASN.

[30]  J. Morrell,et al.  Focal necrotizing panniculitis and vascular necrosis in rats given subcutaneous injections of cocaine hydrochloride , 1997, Journal of cutaneous pathology.

[31]  P. Merry,et al.  Antineutrophil cytoplasmic antibody-positive polyarthritis associated with minocycline therapy. , 1996, British journal of rheumatology.

[32]  M. Yaron,et al.  Minocycline induced arthritis associated with fever, livedo reticularis, and pANCA. , 1996, Annals of the rheumatic diseases.

[33]  P. Mathieson,et al.  Coexistent membranous nephropathy and ANCA-positive crescentic glomerulonephritis in association with penicillamine. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[34]  M. Espié,et al.  Fluoxetin-induced pulmonary granulomatosis. , 1996, The European respiratory journal.

[35]  R. Parry,et al.  Phenytoin-associated vasculitis and ANCA positivity: a case report. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[36]  D. Gard,et al.  Cutaneous Vasculitis Associated with Mefloquine , 1995, Annals of Internal Medicine.

[37]  P. Merkel,et al.  Cocaine-associated cerebral vasculitis. , 1995, Seminars in arthritis and rheumatism.

[38]  R. Wityk,et al.  Diagnosis of probable cocaine-induced cerebral vasculitis by magnetic resonance angiography. , 1995, Southern medical journal.

[39]  M. J. Hurst,et al.  Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis associated with anti-thyroid drug treatment. , 1995, British journal of rheumatology.

[40]  C. Lockwood,et al.  Antigen specificity in hydralazine associated ANCA positive systemic vasculitis. , 1995, QJM : monthly journal of the Association of Physicians.

[41]  M. Tanemoto,et al.  Myeloperoxidase-antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis complicating the course of Graves' disease: report of three adult cases. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[42]  W. Gross,et al.  Antineutrophil cytoplasmic autoantibody testing in vasculitides. , 1995, Rheumatic diseases clinics of North America.

[43]  C. Pusey,et al.  Goodpaststure-like syndrome associated with anti-myeloperoxidase antibodies following pencillamine treatment , 1995 .

[44]  C. Trépo,et al.  Polyarteritis Nodosa Related to Hepatitis B Virus A Prospective Study with Long‐Term Observation of 41 Patients , 1995, Medicine.

[45]  M. Schwartz,et al.  Renal vasculitis associated with ciprofloxacin. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[46]  F. Otsuka,et al.  ANCA‐associated vasculitis and lupus‐like syndrome caused by methimazole , 1995, Clinical and experimental dermatology.

[47]  J. H. Herman,et al.  Vasculitis complicating granulocyte colony stimulating factor treatment of leukopenia and infection in Felty's syndrome. , 1995, The Journal of rheumatology.

[48]  X. Chevalier,et al.  Schoenlein-Henoch purpura with necrotizing vasculitis after cocaine snorting. , 1995, Clinical nephrology.

[49]  S. Finegold,et al.  Vasculitides associated with infections, immunization, and antimicrobial drugs. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[50]  L. Couderc,et al.  Necrotizing vasculitis and exacerbation of psoriasis after granulocyte colony-stimulating factor for small cell lung carcinoma. , 1995, Respiratory medicine.

[51]  K. Welte,et al.  Long‐term safety of treatment with recombinant human granulocyte colony‐stimulating factor (r‐metHuG‐CSF) in patients with severe congenital neutropenias , 1994, British journal of haematology.

[52]  K. Jain.  Cutaneous vasculitis associated with granulocyte colony-stimulating factor. , 1994, Journal of the American Academy of Dermatology.

[53]  B. Burke,et al.  Antineutrophil cytoplasmic autoantibody-positive crescentic glomerulonephritis as a complication of treatment with propylthiouracil in children. , 1994, The Journal of pediatrics.

[54]  H. Kondo,et al.  Antineutrophil cytoplasmic autoantibodies in 6 patients with renal failure and systemic sclerosis. , 1994, The Journal of rheumatology.

[55]  C. Dromer,et al.  Sulfasalazine induced lupus in rheumatoid arthritis. , 1994, The Journal of rheumatology.

[56]  R. Bernstein,et al.  Autoantibodies to myeloperoxidase in idiopathic and drug-induced systemic lupus erythematosus and vasculitis. , 1994, British journal of rheumatology.

[57]  R. Goldschmeding,et al.  Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy , 1993, The Lancet.

[58]  E. Keystone,et al.  Systemic vasculitis following influenza vaccination--report of 3 cases and literature review. , 1993, The Journal of rheumatology.

[59]  L. Scerri,et al.  MEFLOQUINE‐ASSOCIATED CUTANEOUS VASCULITIS , 1993, International journal of dermatology.

[60]  P. Cockwell,et al.  Pulmonary and cutaneous vasculitis following hepatitis B vaccination , 1993, Thorax.

[61]  P. Morrow,et al.  Cerebral vasculitis associated with cocaine abuse. , 1993, Journal of forensic sciences.

[62]  B. F. Jones,et al.  Crescentic glomerulonephritis in a patient taking penicillamine associated with antineutrophil cytoplasmic antibody. , 1992, Clinical nephrology.

[63]  J. Uetrecht,et al.  Antimyeloperoxidase antibodies and adverse reactions to clozapine , 1992, The Lancet.

[64]  H. Ozer,et al.  Digital vasculitis associated with interferon therapy. , 1992, The American journal of medicine.

[65]  J. Hed,et al.  Autoantibodies to leucocyte antigens in hydralazine‐associated nephritis , 1992, Journal of internal medicine.

[66]  B. Troost,et al.  Cerebral Vasculitis Associated With Cocaine Abuse , 1991, Stroke.

[67]  L. Rönnblom,et al.  Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. , 1991, Annals of internal medicine.

[68]  P. Souteyrand,et al.  Drug-induced vasculitides. , 1991, Bailliere's clinical rheumatology.

[69]  A. Sjöholm,et al.  Antibodies to neutrophil granulocyte myeloperoxidase and elastase: autoimmune responses in glomerulonephritis due to hydralazine treatment , 1991, Journal of internal medicine.

[70]  P. Yin.  Ephedrine-induced intracerebral hemorrhage and central nervous system vasculitis. , 1990, Stroke.

[71]  A. Sjöholm,et al.  Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine‐induced lupus , 1990, Clinical and Experimental Immunology.

[72]  M. Frankel,et al.  Biopsy‐proven cerebral vasculitis associated with cocaine abuse , 1990, Neurology.

[73]  K. Welte,et al.  Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia. , 1990, Blood.

[74]  A. Brand,et al.  LEUCOCYTOCLASTIC VASCULITIS DURING GM‐CSF THERAPY , 1989, British journal of haematology.

[75]  D. Klonoff,et al.  Stroke associated with cocaine use. , 1989, Archives of neurology.

[76]  J. Schiller,et al.  Granulocyte-macrophage colony-stimulating factor and vasculitis. , 1989, Annals of internal medicine.

[77]  H. Forman,et al.  Cerebral vasculitis and hemorrhage in an adolescent taking diet pills containing phenylpropanolamine: case report and review of literature. , 1989, Pediatrics.

[78]  B. R. Kaye,et al.  Cerebral vasculitis associated with cocaine abuse. , 1987, JAMA.

[79]  S. Perlman,et al.  Phenylpropanolamine: an over-the-counter drug causing central nervous system vasculitis and intracerebral hemorrhage. Case report and review. , 1987, Neurosurgery.

[80]  K. Calman,et al.  Cutaneous vasculitis associated with interferon. , 1983, European journal of cancer & clinical oncology.

[81]  M. Khangure,et al.  Intracerebral hemorrhage and vasculitis related to ephedrine abuse , 1983, Annals of neurology.

[82]  J. Venulet,et al.  Standardized assessment of drug-adverse reaction associations--rationale and experience. , 1980, International journal of clinical pharmacology, therapy, and toxicology.

[83]  D. Bienfang,et al.  A possible association between influenza vaccination and small-vessel vasculitis. , 1980, Archives of internal medicine.

[84]  Jortner Bs,et al.  Cerebral vasculitis in a drug abuser. , 1978 .

[85]  R. T. Bergeron,et al.  Cerebral microvascular injury in experimental drug abuse. , 1976, Investigative radiology.

[86]  Irey Ns.  Teaching monograph. Tissue reactions to drugs. , 1976 .

[87]  B. Bogdanoff,et al.  Mononeuropathy multiplex as a complication of amphetamine angiitis , 1975, Neurology.

[88]  R. T. Bergeron,et al.  Cerebral vascular changes secondary to amphetamine abuse in the experimental animal. , 1971, Radiology.

[89]  D. Tatter,et al.  Necrotizing angiitis associated with drug abuse. , 1970, The New England journal of medicine.

[90]  R. Raskind,et al.  Intracerebral and subarachnoid hemorrhage following use of methamphetamine ("speed"). , 1970, International surgery.

[91]  L. Cluff,et al.  EPIDEMIOLOGICAL STUDIES OF ADVERSE DRUG REACTIONS. , 1965, American journal of public health and the nation's health.

[92]  P. Zeek.  Periarteritis Nodosa: A Critical Review , 1952 .

[93]  P. Zeek,et al.  Studies on periarteritis nodosa; the differentiation between the vascular lesions of periarteritis nodosa and of hypersensitivity. , 1948, The American journal of pathology.

[94]  C. Kallenberg,et al.  Anca associated vasculitis: occurrence, prediction, prevention, and outcome of relapses , 2001 .

[95]  M. Bousser,et al.  Suspected hepatitis B vaccination related vasculitis. , 1999, The Journal of rheumatology.

[96]  P. Merkel,et al.  Drugs associated with vasculitis. , 1998, Current opinion in rheumatology.

[97]  S. D. House,et al.  Cocaine enhances monocyte migration across the blood-brain barrier. Cocaine's connection to AIDS dementia and vasculitis? , 1998, Advances in experimental medicine and biology.

[98]  B. Leaker,et al.  Autoantibodies to myeloperoxidase in systemic sclerosis. , 1997, The Journal of rheumatology.

[99]  S. Hara,et al.  Antineutrophil cytoplasmic autoantibody-positive crescentic glomerulonephritis associated with thiamazole therapy. , 1996, Nephron.

[100]  T. Yura,et al.  Antineutrophil cytoplasmic antibodies (ANCA)-associated crescentic glomerulonephritis and propylthiouracil therapy. , 1996, Nephron.

[101]  J. Niles.  Antineutrophil cytoplasmic antibodies in the classification of vasculitis. , 1996, Annual review of medicine.

[102]  X. Muñoz,et al.  Cocaine-induced Churg-Strauss vasculitis. , 1996, The European respiratory journal.

[103]  J. Bonnetblanc,et al.  Urticarial vasculitis induced by fluoxetine. , 1995, Dermatology.

[104]  Jain Kk.  Drug-induced cutaneous vasculitis. , 1993 .

[105]  E. Bautz,et al.  Antineutrophil cytoplasmic autoantibodies (ANCA) recognizing a recombinant myeloperoxidase subunit. , 1993, Advances in experimental medicine and biology.

[106]  J. Cabezuelo,et al.  Skin vasculitis, hypokalemia and acute renal failure in rhabdomyolysis associated with cocaine. , 1991, Nephron.

[107]  A. Sjöholm,et al.  Antimyeloperoxidase antibodies in patients with extracapillary glomerulonephritis. , 1990, Nephron.

[108]  C. L. Rumbaugh,et al.  cerebral vasospasm: an angiographic study in Cocaine-and methamphetamine-induced acute , 2022 .